LANTERN PHARMA INC. (LTRN) Capital expenditures 2021–2025
LANTERN PHARMA INC. (LTRN) annual capital expenditure history — cash spent on property, plant and equipment, per SEC filings.
$1,715FY2025 · since FY2021: $15,499 → $1,715
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | $1,715 | -86.4% |
| FY2024 | $12,595 | -32.8% |
| FY2023 | $18,734 | -32.7% |
| FY2022 | $27,844 | +79.7% |
| FY2021 | $15,499 | — |
Capital expenditures are shown as the positive cash amount spent, as reported on the cash-flow statement.
Source: SEC XBRL filings · For reference only · Not investment advice